QHM-2025-4057 A87020.99C..01

The procurement process managed by the NHS North East and North Cumbria Integrated Care Board is focused on healthcare services, specifically targeting areas such as PSA Monitoring, Diabetes Care Planning, and Shared Care Drug Monitoring. Located in Sunderland, UKC, this contract was processed under a Direct Award without a call for competition, meaning no alternative providers were considered due to the unique suitability of the awarded supplier. The contract period spans from 1st April 2025 to 31st March 2026, with services having commenced previously under an implied contract.

The process has reached the award stage with a contract signed on 1st October 2025. The legal framework falls outside the standard Procurement Acts of 2023 and 2024, being conducted under the Health Care Services (Provider Selection Regime) Regulations 2023. This tender offers significant growth opportunities for businesses involved in health service provision, particularly those capable of delivering specialized care services as outlined.

Due to the limited procurement method used, businesses with a track record in healthcare delivery and an ability to demonstrate unique service offerings could have been well-positioned to compete for future similar contracts. Opportunities like this might appeal to established large-scale suppliers familiar with public healthcare systems and adept at working within regulatory frameworks. The involvement of reputable bodies like NHS North East and North Cumbria Integrated Care Board further adds credibility and potential for meaningful business expansion through high-profile projects.